Source: Annual Congress 2002 - COPD: from molecules to man
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Schermer, N. Chavannes, A. Hendriks, R. Dekhuijzen, M. Wouters, H. van den Hoogen, O. van Schayck, C. Van Weel (Nijmegen, Maastricht, The Netherlands). Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice. Eur Respir J 2002; 20: Suppl. 38, 1404

Member's Comments

No comment yet.

Related content which might interest you: Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Inhaled corticosteroid therapy on admission of hospitalized patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 243s Year: 2002 Characteristics of COPD patients treated with inhaled corticosteroid in primary care Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Inhaled corticosteroids are over prescribed in patients with COPD, attending hospital Source: Eur Respir J 2006; 28: Suppl. 50, 429s Year: 2006 Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids Source: Breathe 2010; 6: 365 Year: 2010 Clinical and economic impact of inhaled corticosteroid withdrawal in Spanish COPD patients treated with triple therapy Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 Inhaled steroids prescribing in patients with COPD in the community Source: Eur Respir J 2001; 18: Suppl. 33, 59s Year: 2001 The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004 Patients with moderate asthma symptoms may benefit from short-term inhaled corticosteroid monotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 615s Year: 2007 Inhaled antibiotic therapy in patients with severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab Source: Eur Respir J, 52 (2) 1801025; 10.1183/13993003.01025-2018 Year: 2018 Adherence of stable COPD patients to inhaled pharmacotherapy Source: Annual Congress 2011 - COPD management Year: 2011 Osteoporosis in patients with long-term inhaled corticosteroids treatment Source: Eur Respir J 2007; 30: Suppl. 51, 613s Year: 2007 The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Comparing pneumonia incidence in COPD patients treated with or without inhaled corticosteroid Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Asthma control among patients receiving inhaled corticosteroids in general practice in Thailand Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma Year: 2010 Control of persistent asthma patients on inhaled corticosteroids in a real-life setting Source: Annual Congress 2010 - New insights in the epidemiology of asthma Year: 2010 Impact of inhaled corticosteroid use on outcome in COPD patients hospitalised with pneumonia Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD Year: 2010 Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease Year: 2007